Repinotan

From WikiMD's Wellnesspedia

Repinotan is a 5-HT1A receptor agonist that was under development by Bayer for the potential treatment of cerebral ischemia and stroke. It reached phase II clinical trials but was discontinued.

History[edit | edit source]

Repinotan was first developed by Bayer, a German multinational pharmaceutical and life sciences company. It was initially investigated for its potential use in the treatment of cerebral ischemia and stroke. However, despite reaching phase II clinical trials, the development of Repinotan was eventually discontinued.

Mechanism of Action[edit | edit source]

Repinotan acts as an agonist at the 5-HT1A receptor. 5-HT1A receptors are a subtype of the 5-HT receptor that bind the endogenous neurotransmitter serotonin. They are located in the central and peripheral nervous system and are believed to play a key role in the regulation of mood and anxiety.

Clinical Trials[edit | edit source]

Repinotan underwent phase II clinical trials for its potential use in the treatment of cerebral ischemia and stroke. However, the trials did not yield the desired results, leading to the discontinuation of the drug's development.

Discontinuation[edit | edit source]

Despite the initial promise, the development of Repinotan was discontinued. The reasons for this are not publicly disclosed, but it is common for drugs to be discontinued due to factors such as lack of efficacy, safety concerns, or commercial reasons.

See Also[edit | edit source]


Repinotan Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD